Bullish option flow detected in Avadel Pharmaceuticals with 1,680 calls trading, 2.0x expected, and implied vol increasing almost 3 points to 95.93%. Oct-24 15 calls and Sep-24 15 calls are the most active options, with total volume in those strikes near 1,300 contracts. The Put/Call Ratio is 0.10. Earnings are expected on November 6th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVDL:
- Avadel Pharmaceuticals Advances Pediatric Narcolepsy Treatment Review
- Avadel publishes RESTORE data on LUMRYZ for narcolepsy patients
- Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)
- H.C. Wainwright says buy Avadel selloff, court ruling ‘unequivocal win’
- Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue